Russell Investments Group’s BioVie BIVI Stock Holding History

Russell Investments Group’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$137	–	3307
2023 Q4	$137	Hold	1	–	–	﹤0.01%	3190
2023 Q3	$372	Buy	+1	New	+$391	﹤0.01%	3431

Other funds holding BIVI

ACM

Altium Capital Management New York $42M AUM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Russell Investments Group's BIVI Position: Q1 2024 in Review

Russell Investments Group sold out of BioVie (BIVI) in Q1 2024, closing a stake of 1 share — an estimated $137 sold.

Russell Investments Group first reported a position in BIVI in Q3 2023 and held it in 2 quarters. The position peaked at $372 in Q3 2023. 49 funds tracked by Wall St. Rank hold BIVI as of Q1 2024.

Russell Investments Group reported no remaining BioVie position as of Q1 2024 after selling out during the quarter.
Russell Investments Group sold 1 BioVie share in Q1 2024, an estimated $137.
Russell Investments Group first reported a position in BioVie in Q3 2023 and held it in 2 quarters.
Russell Investments Group's BioVie position peaked at $372 in Q3 2023.
49 funds tracked by Wall St. Rank held BioVie as of Q1 2024.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.